Tehran University Of Medical Sciences
Clinical trials sponsored by Tehran University Of Medical Sciences, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Nasal spray painkiller: can a higher dose work better in the ER? Results expected Mar 2027 (estimated)
-
Nasal spray painkiller: can a higher dose work better in the ER?
Symptom relief Not yet recruitingResearchers are testing whether a 30 mg dose of ketorolac given as a nasal spray relieves acute pain as well as a 20 mg dose in adults who arrive at the emergency department with moderate to severe pain. The trial enrolls 100 people aged 18 to 65 who weigh more than 50 kg and hav…
Phase 3 • Sponsor: Tehran University of Medical Sciences • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Nasal spray showdown: which eases finger block pain better?
Symptom relief Not yet recruitingThis study tests whether a nasal spray of ketorolac (an anti-inflammatory) or ketamine (a pain reliever) works better to reduce pain before a finger nerve block in the emergency room. About 64 adults with finger injuries will receive one of the two sprays, and their pain levels, …
Phase 3 • Sponsor: Tehran University of Medical Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC